Citation Tools

Download PDFPDF
Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer

Download to a citation manager

Cite this article as:
Mayadev J, Zamarin D, Deng W, et al
Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer